Cloprostenol Veyx SW (Canada)

Each 2mL dose of the colorless solution contains:

Active Ingredients

175 µg/2 mL of cloprostenol (as cloprostenol sodium B.P.)

PRESERVATIVES:

0.1 % w/v chlorocresol

Cloprostenol Veyx SW Indications

Cloprostenol Veyx^® SW induces farrowing in sows and gilts. Parturition and piglet viability are normal when Cloprostenol Veyx^® SW is administered as early as 1 or 2 days before the expected farrowing date. Piglet mortality may be increased if Cloprostenol Veyx^® SW is administered earlier than the second day before expected farrowing. The prediction of the precise date of farrowing is subject to error; therefore, the operator should be prepared to render extra care to piglets, if necessary. The average gestation length must be calculated on each farm from accurate service records so that sows may be induced to farrow at the required time. (In most situations gestation length varies between 111 and 119 days with an average around 115 days as shown below.) Sows and gilts may then be given Cloprostenol Veyx^® SW as early in gestation as 2 days before this calculated expected farrowing date. The majority of animals can be expected to respond within the period 24 ± 5 hours following injection, except in those cases where spontaneous farrowing is imminent. Trials have shown that normally 95% will commence farrowing within 36 hours of treatment.

Dosage and Administration

2 mL (175 µg cloprostenol) Cloprostenol Veyx^® SW should be administered by deep intramuscular injection.

CAUTIONS:

An increase in the number of nonviable piglets may result if Cloprostenol Veyx^® SW is used more than two days prior to the average gestation length calculated from farm records.

Warnings

No meat withdrawal period is required when used according to the label. This product should be handled carefully to avoid accidental self-injection or contact with the skin or mucous membranes of the user.

Prostaglandins of the F2α type may readily be absorbed through the skin and may cause bronchospasms and/or miscarriage.

Pregnant women, women of childbearing age, asthmatics and people with other respiratory tract diseases should exercise extreme caution when handling this product such as wearing waterproof gloves.

Accidental spillage on the skin should be washed off immediately with water.

In case of accidental self-injection, seek medical advice and show the package insert to the doctor. Should respiratory distress result from accidental inhalation or injection, the inhalation

of a rapidly acting bronchodilator is indicated.

Keep out of reach of children.

Adverse Reactions

Mild side effects (consisting of exaggerated nesting behavior and restlessness) may be seen occasionally.

Storage

Protect from light. Store between 15° and 30°C. Discard unused product after 28 days of first broaching the vial.

How Supplied

50 mL multidose vials

Manufactured for:

Modern Veterinary Therapeutics, LLC, Sunrise, Florida 33326 - USA

Tel. +1 888 590 9839

info@modernveterinarytherapeutics.com

www.modernveterinarytherapeutics.com

Imported by:

Modern Veterinary Therapeutics Inc., 261065 Wagon Wheel Way, Bay 3, Balzac (Rocky View County), AB T4A 0T5

Orders & Product information: Call 1 888 590 9839

Made in The Netherlands

Revision Date: 19 February 2024

V01.24 (CA) Mus

3307 4 CA - V01.23

CPN: 1354013.4